Insufficient scRNA-seq data for expression of NR5A1 at single-cell level.
Insufficient scRNA-seq data for expression of NR5A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 5062.15 | 180 / 180 | 53% | 7.57 | 230 / 430 |
adrenal gland | 100% | 25464.60 | 258 / 258 | 49% | 192.13 | 113 / 230 |
spleen | 100% | 20856.75 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.75 | 1 / 1 |
thymus | 2% | 2.35 | 14 / 653 | 11% | 0.72 | 65 / 605 |
lung | 4% | 2.23 | 23 / 578 | 7% | 0.91 | 77 / 1155 |
breast | 8% | 7.53 | 36 / 459 | 2% | 0.44 | 27 / 1118 |
peripheral blood | 10% | 4.71 | 89 / 929 | 0% | 0 | 0 / 0 |
uterus | 4% | 7.28 | 6 / 170 | 6% | 0.85 | 26 / 459 |
brain | 7% | 16.95 | 189 / 2642 | 1% | 0.04 | 9 / 705 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.51 | 2 / 29 |
tonsil | 0% | 0 | 0 / 0 | 7% | 1.04 | 3 / 45 |
liver | 5% | 3.32 | 11 / 226 | 2% | 0.06 | 7 / 406 |
esophagus | 3% | 1.68 | 37 / 1445 | 4% | 1.20 | 7 / 183 |
skin | 3% | 2.53 | 63 / 1809 | 2% | 0.96 | 11 / 472 |
stomach | 1% | 2.23 | 4 / 359 | 3% | 0.16 | 9 / 286 |
kidney | 3% | 1.74 | 3 / 89 | 1% | 0.09 | 8 / 901 |
pancreas | 2% | 0.83 | 7 / 328 | 1% | 0.45 | 2 / 178 |
bladder | 0% | 0 | 0 / 21 | 3% | 0.58 | 16 / 504 |
adipose | 3% | 8.07 | 35 / 1204 | 0% | 0 | 0 / 0 |
prostate | 3% | 2.71 | 7 / 245 | 0% | 0 | 0 / 502 |
intestine | 2% | 2.22 | 17 / 966 | 1% | 0.02 | 5 / 527 |
blood vessel | 2% | 4.66 | 24 / 1335 | 0% | 0 | 0 / 0 |
heart | 1% | 0.73 | 10 / 861 | 0% | 0 | 0 / 0 |
muscle | 1% | 0.52 | 6 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030238 | Biological process | male sex determination |
GO_0009888 | Biological process | tissue development |
GO_0001553 | Biological process | luteinization |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0050810 | Biological process | regulation of steroid biosynthetic process |
GO_0060008 | Biological process | Sertoli cell differentiation |
GO_0051457 | Biological process | maintenance of protein location in nucleus |
GO_0007538 | Biological process | primary sex determination |
GO_0030325 | Biological process | adrenal gland development |
GO_2000020 | Biological process | positive regulation of male gonad development |
GO_0009755 | Biological process | hormone-mediated signaling pathway |
GO_0008584 | Biological process | male gonad development |
GO_0033327 | Biological process | Leydig cell differentiation |
GO_0008585 | Biological process | female gonad development |
GO_0042445 | Biological process | hormone metabolic process |
GO_0007530 | Biological process | sex determination |
GO_2000195 | Biological process | negative regulation of female gonad development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005829 | Cellular component | cytosol |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0001221 | Molecular function | transcription coregulator binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NR5A1 |
Protein name | Nuclear receptor subfamily 5 group A member 1 Steroidogenic factor 1 (SF-1) (STF-1) (hSF-1) (Adrenal 4-binding protein) (Fushi tarazu factor homolog 1) (Nuclear receptor subfamily 5 group A member 1) (Steroid hormone receptor Ad4BP) Alternative protein NR5A1 Steroidogenic factor 1 (Nuclear receptor subfamily 5 group A member 1) |
Synonyms | AD4BP SF1 FTZF1 |
Description | FUNCTION: Transcriptional activator. Essential for sexual differentiation and formation of the primary steroidogenic tissues . Binds to the Ad4 site found in the promoter region of steroidogenic P450 genes such as CYP11A, CYP11B and CYP21B. Also regulates the AMH/Muellerian inhibiting substance gene as well as the AHCH and STAR genes. 5'-YCAAGGYC-3' and 5'-RRAGGTCA-3' are the consensus sequences for the recognition by NR5A1 . The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity. Binds phosphatidylcholine (By similarity). Binds phospholipids with a phosphatidylinositol (PI) headgroup, in particular PI(3,4)P2 and PI(3,4,5)P3. Activated by the phosphorylation of NR5A1 by HIPK3 leading to increased steroidogenic gene expression upon cAMP signaling pathway stimulation. . |
Accessions | L8ECB8 ENST00000373588.9 A0A1E1GJF0 F1DAM0 B6ZGU8 Q13285 Q5T6F7 Q5T6F6 ENST00000455734.1 ENST00000373587.3 ENST00000620110.4 F1D8R8 |